Buckingham Strategic Wealth’s Labcorp LH Stock Holding History

Buckingham Strategic Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,814	Closed	-$280K	–	366
2018 Q2	$280K	Buy	+1,814	New	+$274K	0.05%	278

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Buckingham Strategic Wealth's LH Position: Q3 2018 in Review

Buckingham Strategic Wealth sold out of Labcorp (LH) in Q3 2018, closing a stake of 1,814 shares — an estimated $280K sold.

Buckingham Strategic Wealth first reported a position in LH in Q2 2018 and held it in 1 quarter. The position peaked at $280K in Q2 2018. 793 funds tracked by Wall St. Rank hold LH as of Q3 2018.

Buckingham Strategic Wealth reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
Buckingham Strategic Wealth sold 1,814 Labcorp shares in Q3 2018, an estimated $280K.
Buckingham Strategic Wealth first reported a position in Labcorp in Q2 2018 and held it in 1 quarter.
Buckingham Strategic Wealth's Labcorp position peaked at $280K in Q2 2018.
793 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Buckingham Strategic Wealth's 13F filing for Q3 2018, filed 2 Nov 2018.